ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
OSE Immunotherapeutics

OSE Immunotherapeutics (OSE)

7.27
0.21
(2.97%)
Closed 29 December 3:30AM

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 34.74M6.68M24.46M25.95M10.43M26.31M18.3M2.23M
Operating Income 17.5M-12.63M4.95M-1.47M-18.99M-16.6M-18.4M-22.99M
Pre Tax Income 17.59M-12.74M4.71M-1.46M-19.25M-17.21M-18.02M-23.22M
Net Income 20.67M-10.5M5.49M-4.65M-16.56M-16.85M-17.76M-23M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 1.446-0.7250.371-0.31-0.921-0.909-0.959-1.062
EBIT 17.5M-12.63M4.85M-1.47M-18.99M-16.63M-18.48M-22.99M
EBITDA 17.5M-12.59M4.97M-989k-18.26M-13.94M-14.84M-19.46M

Your Recent History

Delayed Upgrade Clock